Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone in First-Line Extensive Disease SCLC
NCT00299390Phase 2Terminated
- Sponsor
- Bayer
- Start
- Apr 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sagopilone in small cell lung cancer (SCLC), sponsored by Bayer. Started Apr 2006; status: terminated.
02
Drugs
sagopilone
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00299390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299390.